Evidence map›Paper›PMID 26491670›Full record

ArticleBioMed research international2015

Immunomodulation by Zearalenone in Carp (Cyprinus carpio L.).

Constanze Pietsch, Ranka Junge, Patricia Burkhardt-Holm

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Constanze PietschZurich University of Applied Sciences (ZHAW), Institute of Natural Resource Sciences (IUNR), Gruental, 8820 Waedenswil, Switzerland ; Man-Society-Environment, Department of Environmental Sciences, University Basel, Vesalgasse 1, 4051 Basel, Switzerland.
Ranka JungeZurich University of Applied Sciences (ZHAW), Institute of Natural Resource Sciences (IUNR), Gruental, 8820 Waedenswil, Switzerland.
Patricia Burkhardt-HolmMan-Society-Environment, Department of Environmental Sciences, University Basel, Vesalgasse 1, 4051 Basel, Switzerland ; Department of Biological Sciences, University of Alberta, CW 405 Biological Sciences Building, Edmonton, AB, Canada T6G 2E9.
ZHAW Zurich University of Applied Sciences · CHUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mycotoxin zearalenone (ZEN) is a frequent contaminant of animal feeds, but its effects on fish have not yet been investigated extensively. In order to fill this gap a feeding trial with juvenile carp was conducted. Three groups of fish were fed feeds contaminated with ZEN at three concentrations (low: 332 μg kg(-1), medium: 621 μg kg(-1), and high: 797 μg kg(-1) feed) for four weeks. Possible reversible effects of ZEN were evaluated by feeding additional groups with the ZEN-contaminated feeds for four weeks, followed by the uncontaminated diet for two weeks. Immune function of isolated leukocytes from head kidney and trunk kidney was assessed using the assessment of NO production, the respiratory burst assay, the chemiluminescence assay, and the measurement of arginase activities. These investigations frequently revealed increased immune responses after exposure of fish to low ZEN concentrations and reduced immune responses after exposure to high mycotoxin concentrations. Moreover, the feeding of the uncontaminated diet for further two weeks did not improve the immune responses in most cases. These results indicate that cellular immune functions in ZEN-contaminated carp are influenced which may be relevant for fish health in aquaculture.

Indexed as

Animal FeedAnimalsCarpsFish DiseasesImmunomodulationKidneyLeukocytesNitric OxideZearalenoneNitric OxideZearalenone

Identifiers

PMID26491670
PMCPMC4603321
OpenAlexW2152201763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.